SCHEMBL4640064

SCHEMBL4640064

CCCC(C)(C)OC(=O)c1ccc(C)cc1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.42
TRPM2 O94759 2/20 0.37
NOTUM Q6P988 1/20 0.37
SORT1 Q99523 1/20 0.36
PLK1 P53350 11/20 0.36
TTR P02766 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C8 P10632 1/20 0.35
CHRM1 P11229 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
ADRA1A P35348 1/20 0.35
PPARG P37231 1/20 0.35
HTR2B P41595 1/20 0.35
PPARA Q07869 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLCO1B3 Q9NPD5 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CISD1 Q9NZ45 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640059 0.93 TAS1R3 (0.36) CSNK2A1TTRCYP1A2CYP2C8CHRM1
SCHEMBL7191047 0.86 METAP2 (0.39) SORT1TSHRPPARGPPARASMN1; SMN2
SCHEMBL4640063 0.84 KMT2A (0.46) TSHRSMN1; SMN2TDP1MEN1KMT2A
SCHEMBL4640225 0.84 KEAP1 (0.41) NOTUMTSHRKMT2A
SCHEMBL4639901 0.84 POLB (0.42) SORT1SMN1; SMN2
SCHEMBL4641156 0.84 PTPRC (0.36) PPARGPPARASMN1; SMN2MEN1KMT2A
SCHEMBL4644128 0.84 HSD17B10 (0.33) NOTUMSORT1CYP2C9TSHR
SCHEMBL17690443 0.82 ALDH1A1 (0.47) TSHRTDP1MEN1KMT2A
SCHEMBL28778814 0.82 CSNK2A1 (0.50) CSNK2A1NOTUMSORT1PPARGPPARA
SCHEMBL4640049 0.81 GABRP (0.34) TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX CSNK2A1 3362/4885TRPM2 3436/4885NOTUM 1837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.